Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults - BioLegacy Research

Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults

Post author:Sam
Post published:February 14, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace